ESMO Expert Consensus Statements on Cancer Survivorship: promoting high-quality survivorship care and research in Europe
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
ESMO Expert Consensus Statements on Cancer Survivorship : promoting high-quality survivorship care and research in Europe. / Vaz-Luis, I.; Masiero, M.; Cavaletti, G.; Cervantes, A.; Chlebowski, R. T.; Curigliano, G.; Felip, E; Ferreira, A. R.; Ganz, P. A.; Hegarty, J.; Jeon, J.; Johansen, C.; Joly, F.; Jordan, K.; Koczwara, B.; Lagergren, P.; Lambertini, M.; Lenihan, D.; Linardou, H.; Loprinzi, C.; Partridge, A. H.; Rauh, S.; Steindorf, K.; van der Graaf, W.; van de Poll-Franse, L.; Pentheroudakis, G.; Peters, S.; Pravettoni, G.
I: Annals of Oncology, Bind 33, Nr. 11, 2022, s. 1119-1133.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - ESMO Expert Consensus Statements on Cancer Survivorship
T2 - promoting high-quality survivorship care and research in Europe
AU - Vaz-Luis, I.
AU - Masiero, M.
AU - Cavaletti, G.
AU - Cervantes, A.
AU - Chlebowski, R. T.
AU - Curigliano, G.
AU - Felip, E
AU - Ferreira, A. R.
AU - Ganz, P. A.
AU - Hegarty, J.
AU - Jeon, J.
AU - Johansen, C.
AU - Joly, F.
AU - Jordan, K.
AU - Koczwara, B.
AU - Lagergren, P.
AU - Lambertini, M.
AU - Lenihan, D.
AU - Linardou, H.
AU - Loprinzi, C.
AU - Partridge, A. H.
AU - Rauh, S.
AU - Steindorf, K.
AU - van der Graaf, W.
AU - van de Poll-Franse, L.
AU - Pentheroudakis, G.
AU - Peters, S.
AU - Pravettoni, G.
N1 - Publisher Copyright: © 2022 European Society for Medical Oncology
PY - 2022
Y1 - 2022
N2 - Background: The increased number of cancer survivors and the recognition of physical and psychosocial challenges, present from cancer diagnosis through active treatment and beyond, led to the discipline of cancer survivorship. Design and methods: Herein, we reflected on the different components of survivorship care, existing models and priorities, in order to facilitate the promotion of high-quality European survivorship care and research. Results: We identified five main components of survivorship care: (i) physical effects of cancer and chronic medical conditions; (ii) psychological effects of cancer; (iii) social, work and financial effects of cancer; (iv) surveillance for recurrences and second cancers; and (v) cancer prevention and overall health and well-being promotion. Survivorship care can be delivered by structured care models including but not limited to shared models integrating primary care and oncology services. The choice of the care model to be implemented has to be adapted to local realities. High-quality care should be expedited by the generation of: (i) focused and shared European recommendations, (ii) creation of tools to facilitate implementation of coordinated care and (iii) survivorship educational programs for health care teams and patients. The research agenda should be defined with the participation of health care providers, researchers, policy makers, patients and caregivers. The following patient-centered survivorship research areas were highlighted: (i) generation of a big data platform to collect long-term real-world data in survivors and healthy controls to (a) understand the resources, needs and preferences of patients with cancer, and (b) understand biological determinants of survivorship issues, and (ii) develop innovative effective interventions focused on the main components of survivorship care. Conclusions: The European Society for Medical Oncology (ESMO) can actively contribute in the efforts of the oncology community toward (a) promoting the development of high-quality survivorship care programs, (b) providing educational material and (c) aiding groundbreaking research by reflecting on priorities and by supporting research networking.
AB - Background: The increased number of cancer survivors and the recognition of physical and psychosocial challenges, present from cancer diagnosis through active treatment and beyond, led to the discipline of cancer survivorship. Design and methods: Herein, we reflected on the different components of survivorship care, existing models and priorities, in order to facilitate the promotion of high-quality European survivorship care and research. Results: We identified five main components of survivorship care: (i) physical effects of cancer and chronic medical conditions; (ii) psychological effects of cancer; (iii) social, work and financial effects of cancer; (iv) surveillance for recurrences and second cancers; and (v) cancer prevention and overall health and well-being promotion. Survivorship care can be delivered by structured care models including but not limited to shared models integrating primary care and oncology services. The choice of the care model to be implemented has to be adapted to local realities. High-quality care should be expedited by the generation of: (i) focused and shared European recommendations, (ii) creation of tools to facilitate implementation of coordinated care and (iii) survivorship educational programs for health care teams and patients. The research agenda should be defined with the participation of health care providers, researchers, policy makers, patients and caregivers. The following patient-centered survivorship research areas were highlighted: (i) generation of a big data platform to collect long-term real-world data in survivors and healthy controls to (a) understand the resources, needs and preferences of patients with cancer, and (b) understand biological determinants of survivorship issues, and (ii) develop innovative effective interventions focused on the main components of survivorship care. Conclusions: The European Society for Medical Oncology (ESMO) can actively contribute in the efforts of the oncology community toward (a) promoting the development of high-quality survivorship care programs, (b) providing educational material and (c) aiding groundbreaking research by reflecting on priorities and by supporting research networking.
KW - cancer
KW - quality of life
KW - survivorship care
KW - survivorship research
U2 - 10.1016/j.annonc.2022.07.1941
DO - 10.1016/j.annonc.2022.07.1941
M3 - Journal article
C2 - 35963481
AN - SCOPUS:85138184025
VL - 33
SP - 1119
EP - 1133
JO - Annals of Oncology
JF - Annals of Oncology
SN - 0923-7534
IS - 11
ER -
ID: 324595293